Kemal Çağlar Göğebakan

MedicineBiochemistry, Genetics and Molecular BiologyMathematics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Short-term Endpoints for Cancer Screening Trials: Does Tumor Subtype Matter?”.

Short-term Endpoints for Cancer Screening Trials: Does Tumor Subtype Matter?

Cancer Epidemiology Biomarkers & Prevention(2023)10.1158/1055-9965.epi-22-1307

N/A

0.208DataRank · unranked

3 citations

Kemal Çağlar Göğebakan, Usha Menon, Roman Gulati, Noel S. Weiss, Ruth Etzioni +1 more

Test sensitivity in a prospective cancer screening program: A critique of a common proxy measure

Statistical Methods in Medical Research(2023)10.1177/09622802221142529

N/A

0DataRank · unranked

9 citations

Yibai Zhao, Kemal Çağlar Göğebakan, Antonio Olivas‐Martínez, Marc D. Ryser, Charlotte C. Gard +2 more